Central Retinal Vein Occlusion Presumably Associated with Lupus Anticoagulant Induced by SARSCoV-2. (17th November 2022)

• Record Type: Journal Article
• Authors: Cuadros Sánchez, Carlos; Egüen, Cristina Sacristán; Gutierrez-Ezquerro, Raquel; Giralt-Peret, Lena; Fonollosa, Alex
• Is Part Of: Ocular immunology and inflammation. Volume 30:Number 7/8(2022)
• Page Start: 2010
• Page End: 2013
• Publication Date: 2022-11-17
• Subjects: COVID-19 -- sars cov-2 -- central retinal vein occlusion -- lupus anticoagulant -- macular edema -- ozurdex; Eye -- Diseases -- Immunological aspects -- Periodicals; Eye -- Inflammation -- Periodicals; 617.7
• DOI: 10.1080/09273948.2021.1933077
• Languages: English
• ISSNs: 0927-3948

Abstract

ABSTRACT: Purpose: To report a case of unilateral central retinal vein occlusion (CRVO) and macular edema presumably associated with lupus anticoagulant (LA) induced by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). Method: Case report. Results: A 32-year-old male patient presented to the emergency department with a 5-day history of blurry vision. He was diagnosed with a CRVO and macular edema. The only pathological finding was positive LA which could have been induced by his recent confirmed SARS CoV-2 infection. The patient's evolution was satisfactory after two injections of Intravitreal dexamethasone (Ozurdex®), with improvement in macular edema and visual acuity. Conclusion: COVID-19 may be associated to retinal vascular occlusive disorders. Transient virus-induced LA might play a role in the pathogenesis of the thrombotic event.